SuperworthMettler-Toledo International profit margin MTD
Gross, operating and net profit as a share of revenue over the last twelve months, from 2010.
- Net margin, 12 months
- 21.9%
- Operating margin, 12 months
- 27.8%
- Net margin on a year earlier
- +0.4 pts
- Peer median
- 8.9%
Over the twelve months to Jun 30, 2026, Mettler-Toledo International kept 21.9% of its revenue as net profit, with an operating margin of 27.8% and a gross margin of 60.3%.
Five years earlier its net margin was 20.5%.
The median for 10 diagnostics and research stocks of a similar size is 8.9%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 21.6% | 27.3% | 59.4% |
| FY2024 | 22.3% | 28.6% | 60.1% |
| FY2023 | 20.8% | 27.6% | 59.2% |
| FY2022 | 22.3% | 28.5% | 58.9% |
| FY2021 | 20.7% | 26.6% | 58.4% |
| FY2020 | 19.5% | n/a | 58.4% |
| FY2019 | 18.6% | n/a | 57.9% |
| FY2018 | 17.5% | n/a | 57.4% |
| FY2017 | 13.8% | 22.0% | 57.8% |
| FY2016 | 15.3% | 21.6% | 57.2% |
| FY2015 | 14.7% | 20.5% | 56.4% |
| FY2014 | 13.6% | 19.0% | 54.7% |
| FY2013 | 12.9% | 18.0% | 53.9% |
| FY2012 | 12.4% | 17.4% | 53.0% |
| FY2011 | 11.7% | 16.2% | 52.8% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 21.9% | +0.4 pts | 27.8% | |
| Q1 FY26 | 21.4% | −0.8 pts | 27.0% | |
| Q4 FY25 | 21.6% | −0.7 pts | 27.3% | |
| Q3 FY25 | 21.2% | +0.1 pts | 27.7% | |
| Q2 FY25 | 21.5% | +0.5 pts | 28.1% | |
| Q1 FY25 | 22.2% | +1.6 pts | 28.3% | |
| Q4 FY24 | 22.3% | +1.5 pts | 28.6% | |
| Q3 FY24 | 21.1% | −1.1 pts | 27.3% | |
| Q2 FY24 | 21.0% | −1.5 pts | 27.2% | |
| Q1 FY24 | 20.5% | −1.9 pts | 27.5% | |
| Q4 FY23 | 20.8% | −1.4 pts | 27.6% | |
| Q3 FY23 | 22.2% | +0.8 pts | 29.1% |
Against its peers
Companies in Medical - Diagnostics & Research nearest Mettler-Toledo International's size, closest first, today.
| Company | Profit margin |
|---|---|
| MTDMettler-Toledo International | 21.9% |
| ILMNIllumina | 18.4% |
| DGXQuest Diagnostics | 9.2% |
| LHLabcorp | 7.0% |
| IDXXIDEXX Laboratories | 25.0% |
| WATWaters | 3.6% |
| IQVIQVIA | 8.1% |
| AAgilent Technologies | 19.5% |
| MEDPMedpace | 17.7% |
| RVTYRevvity | 8.2% |
| BIOBio-Rad Laboratories | 8.6% |
| Peer median | 8.9% |
Where Mettler-Toledo International ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Mettler-Toledo International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.